Literature DB >> 330116

The use of nitroaromatic compounds as hypoxic cell radiosensitizers.

P Wardman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330116

Source DB:  PubMed          Journal:  Curr Top Radiat Res Q        ISSN: 0011-3964


× No keyword cloud information.
  14 in total

1.  The rationale for the development of improved hypoxic cell radiosensitizers.

Authors:  P Wardman; E D Clarke; I R Flockhart; R G Wallace
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 2.  Redox properties and rate constants in free-radical mediated damage.

Authors:  P Wardman; E D Clarke
Journal:  Br J Cancer Suppl       Date:  1987-06

3.  Reduction of nitroaromatic compounds mediated by Streptomyces sp. exudates.

Authors:  M A Glaus; C G Heijman; R P Schwarzenbach; J Zeyer
Journal:  Appl Environ Microbiol       Date:  1992-06       Impact factor: 4.792

4.  Nitroaromatic radiation sensitizers substitute for oxygen in neocarzinostatin-induced DNA damage.

Authors:  L S Kappen; I H Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

Review 5.  Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.

Authors:  D I Edwards
Journal:  Br J Vener Dis       Date:  1980-10

6.  Inhibition of plant fatty acid synthesis by nitroimidazoles.

Authors:  A V Jones; J L Harwood; M R Stratford; P K Stumpf
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

7.  Effect of anoxic radiosensitizers on cellular and mitochondrial oxygen consumption and respiration control ratio.

Authors:  I Mustea; A Bara; I Petrescu; L Révész
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 8.  Cellular approaches to bioreductive drug mechanisms.

Authors:  A M Rauth; R S Marshall; B L Kuehl
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

9.  Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis.

Authors:  S N Moreno; R Docampo
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

10.  A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy.

Authors:  C P Lee; G S Payne; A Oregioni; R Ruddle; S Tan; F I Raynaud; D Eaton; M J Campbell; K Cross; G Halbert; M Tracy; J McNamara; B Seddon; M O Leach; P Workman; I Judson
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.